Cellectis SA (CLLS)
3.78
+0.29
(+8.31%)
USD |
NASDAQ |
Feb 13, 14:21
Cellectis Free Cash Flow : -34.73M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| EDAP TMS SA | -- |
| DBV Technologies SA | -98.65M |
| Ascendis Pharma A/S | 51.45M |
| Akari Therapeutics Plc | -9.678M |
| Biodexa Pharmaceuticals Plc | -14.30M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.627M |
| Cash from Investing (Quarterly) | -3.266M |
| Cash from Financing (Quarterly) | -4.089M |
| Free Cash Flow Per Share (Quarterly) | -0.0391 |
| Free Cash Flow to Equity (Quarterly) | -9.372M |
| Free Cash Flow to Firm (Quarterly) | -4.857M |
| Free Cash Flow Yield | -9.82% |